addiction
NYTimes: Are You Addicted to Weed? – Cannabis | Weed | Marijuana
Published
2 years agoon
By
admin
The New York Times is asking: are you addicted to weed? And if you were, would you even know?
That’s what the “paper of record,” is asking, with the warning that nearly six percent of American teens and adults have “cannabis use disorder.”
Many used to highly regard the New York Times due to its reputation for high-quality journalism. In recent years, the paper’s accuracy, objectivity, and editorial decisions have suffered, particularly in the age of social media and the 24-hour news cycle.
From presidential elections to the covid hysteria to the Russian-Ukraine war – the New York Times has devolved into a Tumblr blog.
The article “How Do You Know if You’re Addicted to Weed?” is not high-quality journalism. The journalism of their past – like breaking the Iran-Contra Affair or revealing the Pentagon Papers – would likely be considered “harmful misinformation” now.
Just look at how they treated the Hunter-Biden laptop scandal. Or how they covered the covid lab-leak hypothesis. Search “NYTimes” and “Joe Rogan” and see how their jealousy manifests.
The New York Times is no longer the paper of record unless that record is writing advertisements for corporate sponsors.
And this is what the NYTimes “addicted to weed” article amounts to—advertising for anxiety meds.
NYTimes: Are You Addicted to Weed?
The NYTimes is asking: are you addicted to weed? And to be fair, this article is not as bad as it could have been. It opens with an adult named Julian, who always smoked weed instead of forming friendships or other relationships.
Julian didn’t even think he had a problem until someone suggested he was “addicted to weed.” So he looked up the definition of “cannabis use disorder” online and self-diagnosed himself.
Funny, the “experts” discourage that in almost every other situation.
The Ontario government, for example, has launched a “Stop Going Down Rabbit Holes” campaign.
Despite healthcare shortages and overcrowded hospitals, the Ontario government wants you to speak with a professional about common medical ailments (like whether you should apply heat or cold to a sprain) instead of doing any research yourself.
The NYTimes “addicted to weed” article says that cannabis is addictive like alcohol or cocaine. They admit it won’t cause an overdose death like opiates. But it can cause a “dramatic decrease in quality of life.”
This line needs some nuance, but unfortunately, the quoted psychiatrist doesn’t go into detail.
Alcohol, for example, can cause a dramatic decrease in your quality of life whether you see your drinking as problematic or not. Mentally, you could be fine. But physically, you’re body is processing a literal poison.
While you could make a case that smoking cannabis harms the lungs, if you’re consuming edibles or extracts, cannabis will not physically destroy your body. Nor does it kill brain cells the way alcohol or cocaine will.
So how does cannabis cause a dramatic decrease in quality of life?
Signs of Addiction or “Cannabis Use Disorder”
This NYTimes “addicted to weed” article uses the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) as an authoritative text. You might recognize its other name – the DSM-5.
But the DSM consists of cultural conventions, not scientific concepts. A “caffeeine use disorder” is not listed despite the 74% of Americans who drink coffee daily.
The main reason is that telling millions of Americans they have a substance abuse problem is counterproductive.
As well, we normalize daily caffeine consumption. Even if you told 74% of Americans that they had a problematic relationship with coffee, they’d ask you to mind your own business.
Appealing to the DSM-5 as the be-all, end-all of the discussion on “cannabis use disorder” is an appeal to authority, a logical fallacy. For, the criteria it provides aren’t even scientific.
Consider the concept of “loss of control.” No scientific evidence supports it. You may find some conditional evidence in neurobiology, but this has yet to establish causation. You may also find some observational research that supports it.
But the gold standard in science is demonstrating cause and effect.
The DSM-5 is a product of culture. Particularly a culture that’s been captivated by drug war propaganda.
According to the DSM-5, developing tolerance to THC and experiencing withdrawal symptoms (which could be as benign as insomnia or irritability) means you’re addicted to weed, or, to be politically correct, you have “cannabis use disorder.”
What Actually Causes Addiction?
The NYTimes “addicted to weed” article quotes Dr. David Gorelick. He said, “Cannabis use disorder occurs in all age groups, but it’s primarily a disease of young adults.”
What goes unsaid is that most people with “addiction” issues are young adults because, by their 30s, these issues resolve naturally.
The research is conclusive: Most young adults with drug-dependency issues recover independently without the need for formal treatment. They do this by their 30s.
Of course, the NYTimes “addicted to weed” article ignores this research. It does not fit the “public health” narrative that some drugs are harmful and addictive that require treatment. While others (the ones produced and patented by pharma) are good and healthy that require taxpayer-financed subsidies.
Also, when you view human action as a consequence of forces beyond our control, a cultural phenomenon – addiction – can be construed as a “disease” of the brain.
But despite the NYTimes’ “addicted to weed” propaganda, little evidence supports the brain-disease theory of drug addiction.
The myth persists because there are financial incentives to “treat” addiction as a “disease” rather than what it actually is – a problem with the mind.
Hidden in the NYTimes “addicted to weed” article is the truth.
Having another psychiatric diagnosis, such as anxiety, depression, post-traumatic stress disorder or attention deficit hyperactivity disorder, is also associated with an increased risk [of cannabis addiction].
As one of the doctors in the article says, it’s possible to consume daily and not have a “disorder.”
The people who continue to use cannabis despite negative consequences are people with other issues. They are self-medicating with cannabis. And given the options, cannabis will be preferable to opiates or alcohol. Or even SSRIs.
NYTimes: Addicted to Weed? Here Are Your Options
So what does the NYTimes “addicted to weed” article recommend? There are no approved medications to “treat” a cannabis “disorder.” But that doesn’t stop psychiatrists from prescribing medication.
The article does reference cognitive behavioral therapy but in the context of treatment and recovery. Where you’re developing strategies to “deal with cravings” or “triggers.”
Instead of fundamentally changing your preferences.
(For example, many of us prefer not to drink coffee later in the afternoon. Most of us aren’t dealing with cravings or developing strategies to cope. We simply don’t want to consume caffeine in the afternoon based on our preferences.)
Yet, despite the attempts of the NYTimes to make a case of being addicted to weed, the reality comes crashing down in the final paragraph: “Julian now smokes weed very rarely — only once every few months if an old friend is around. He doesn’t miss it, he said.”
If Julian’s use was a disease of the brain, then how is this possible? Or was Julian’s “disorder” a coping mechanism for stress and anxiety? Could it be that Julian resolved his anxiety issues and now has a “take it or leave it” approach to cannabis?
This wouldn’t be possible if it were the pharmacology of the drug causing addiction. If Julian’s brain was diseased, wouldn’t a “relapse” compel him back into chronic use?
Or perhaps the brain disease or “disorder” model is bunk.
Feeling Addicted? Try some CBD
If you prefer anti-anxiety pills from pharmaceutical companies – that’s your prerogative. And if anxiety is the problem, most people don’t recommend a diet high in THC.
At least add some CBD into the mix.
But don’t let the “experts” convince you that you have a disease or disorder.
It could be that your cannabis use is problematic. But that would be a sign of an underlying issue. Of some fundamental preference you may not fully understand.
What it isn’t is a disease like cancer or myocarditis. It’s a habit. And for the 6% minority, it’s a self-destructive habit.
So in that sense, the NYTimes is wrong; you cannot get addicted to weed. Cannabis is a flower. And flowers can’t force you to do things against your will.
You may like
-
Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?
-
Hemp and the New Senate Farm Bill
-
The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?
-
Minnesota Office of Cannabis Management Issues Rejections to Majority of Social Equity Applicants
-
Find LivWell in Colorado
-
Find Verilife in Massachusetts
addiction
Can Psychedelics Treat Addiction and Alcoholism?
Published
2 months agoon
September 13, 2024By
admin
Psychedelics, once associated primarily with counterculture and recreational drug use, are now being seriously studied for their therapeutic potential in treating drug addiction and alcoholism. Recent research has shown that substances like psilocybin, LSD, and ayahuasca may have profound benefits for individuals struggling with Alcohol Use Disorder (AUD) and substance use disorders (SUD). These compounds are being reconsidered not only for their ability to induce altered states of consciousness but also for their potential to address addictive behaviors and psychological trauma at the root of addiction.
Psilocybin’s Efficacy in Treating Alcohol Use Disorder
One groundbreaking study, conducted at New York University and Johns Hopkins University, demonstrated the potential of psilocybin in treating Alcohol Use Disorder (AUD). The researchers focused on individuals with severe AUD, administering two doses of psilocybin in conjunction with psychotherapy. The results were notable: participants reported a 50% reduction in heavy drinking days over an eight-month period, with some maintaining abstinence from alcohol even a year later.
The trial followed a double-blind, randomized approach and found that the therapeutic effects of psilocybin were superior to those observed with placebo treatments. Dr. Michael Bogenschutz, a lead researcher in the study, emphasized the importance of the psychedelic experience itself in breaking the cycle of addiction. Psilocybin appears to help patients break through entrenched mental patterns, often revealing deeper emotional connections and realizations that drive more meaningful behavior change.
How Psychedelics Influence the Brain to Combat Addiction
The mechanism behind the efficacy of psychedelics in treating addiction is thought to involve neuroplasticity, or the brain’s ability to reorganize and form new connections. By interacting with serotonin 2A receptors, particularly in the prefrontal cortex and default mode network, psychedelics can enable profound shifts in perception and cognition. These altered states of consciousness allow individuals to confront underlying psychological issues, such as trauma or negative emotional patterns, which are often at the core of addictive behaviors.
Many individuals undergoing psychedelic-assisted therapy report experiencing a “reset” of their mental state, facilitating a more open mindset that helps them engage with therapy in a deeper, more effective way. This contrasts with traditional addiction treatments, such as methadone or buprenorphine, which primarily manage withdrawal symptoms but do not address the psychological components of addiction.
LSD and Its Potential in Addiction Treatment
LSD (lysergic acid diethylamide) has also shown promise in treating addiction, particularly alcoholism. Early studies from the 1950s to the 1970s suggested that LSD might help reduce alcohol dependency, but interest in this line of research waned due to regulatory crackdowns on psychedelic research. However, more recent studies have reignited interest in LSD’s therapeutic potential.
A meta-analysis published in the Journal of Psychopharmacology reviewed data from six trials involving over 500 patients. It concluded that a single high dose of LSD, administered in a therapeutic setting, was associated with a significant reduction in alcohol consumption. The study found that LSD’s psychedelic effects could lead to lasting changes in personality traits, such as openness and emotional resilience, which are crucial for overcoming addiction.
Ayahuasca and Addiction Recovery
Ayahuasca, a traditional Amazonian brew containing DMT (dimethyltryptamine) and MAO inhibitors, has been the focus of recent studies examining its potential to treat addiction. Researchers have found that ayahuasca’s intense psychoactive properties, combined with its ability to facilitate introspection and emotional healing, may help individuals overcome opioid and stimulant addiction. A study published in Frontiers in Pharmacology noted that ayahuasca led to significant improvements in mental health and reductions in addictive behaviors.
Ayahuasca ceremonies, often conducted in a spiritual context, have been shown to promote healing through vivid and sometimes challenging visions. Participants often report gaining insights into the underlying causes of their addiction, leading to long-lasting psychological benefits.
Challenges in Psychedelic-Assisted Therapy
While the results of these studies are promising, the use of psychedelics in treating addiction is not without challenges. For one, the psychedelic experience itself can be unpredictable, and not all patients experience the profound mystical or emotional breakthroughs associated with positive outcomes. The effectiveness of psychedelic-assisted therapy appears to be linked to the quality of the therapeutic environment and the expertise of the facilitators, meaning that careful preparation and integration are key to success.
Moreover, while psychedelics like psilocybin and LSD do not appear to be physically addictive, their use must still be carefully regulated to prevent potential psychological risks, such as hallucinations, anxiety, or psychotic episodes in vulnerable individuals. Current research emphasizes the need for controlled settings where trained therapists can guide patients through their psychedelic experiences.
Ongoing Research and Future Directions
Given the promising early results, psychedelic research is entering a new phase, with larger clinical trials currently underway. The National Institutes of Health (NIH) recently allocated $2.4 million to explore the use of psychedelics in treating methamphetamine addiction, further solidifying the role of psychedelics in addiction therapy. Similarly, ongoing studies are looking into psilocybin’s potential to treat opioid addiction and cocaine dependence, conditions that have been notoriously difficult to treat with conventional methods.
As research progresses, it is likely that psilocybin, LSD, and other psychedelics will become more widely recognized as effective tools for addiction treatment. While more research is needed to fine-tune these therapies and better understand their long-term effects, early indications are that psychedelics could revolutionize addiction and alcoholism treatments in the coming decades.
Conclusion
Psychedelics like psilocybin, LSD, and ayahuasca are emerging as potential breakthrough therapies for treating drug addiction and alcoholism. By promoting neuroplasticity and addressing the psychological roots of addiction, these substances offer an alternative to traditional addiction treatments, which often focus on managing symptoms rather than curing the disease. With ongoing research and increasing clinical trials, psychedelic-assisted therapy may become an essential tool in the fight against substance use disorders, offering hope to millions of people who struggle with addiction, such as alcoholism.
Sources
Johns Hopkins Medicine: Psychedelics in Addiction Treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry
National Institutes of Health (NIH) Research on Psychedelics
Frontiers in Pharmacology: Ayahuasca for Addiction Recovery
JAMA Otolaryngology – Head & Neck Surgery
Related
addiction
The Evolving Opioid Crisis in Europe: Heroin and Synthetic Threats
Published
2 months agoon
September 12, 2024By
admin
The opioid crisis in Europe is growing in complexity, with heroin continuing to dominate the market while synthetic opioids, such as fentanyl and its analogs, emerge as potent new threats. The 2024 EU Drug Markets Report, released by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and Europol, provides a comprehensive analysis of the heroin and synthetic opioid market, detailing the health risks, evolving trafficking routes, and potential future challenges.
Heroin in Decline? Why Synthetic Opioids Pose a New Threat in Europe
Heroin’s Ongoing Impact in Europe
Heroin remains the most commonly used illicit opioid in Europe, with an estimated 1 million high-risk opioid users. The European heroin market is valued at over €5.2 billion annually, indicating the persistent demand for this drug. In 2021, EU countries seized 9.5 tonnes of heroin, the largest quantity in 20 years. These figures underscore the strong presence of heroin in Europe, despite the introduction of harm reduction programs aimed at curbing opioid use.
The health consequences of heroin use are severe. In 2021, opioids were responsible for three-quarters of Europe’s 6,000 drug-related overdose deaths, with heroin being a leading factor. Long-term users are aging, adding complexity to public health strategies, as older opioid users present with more chronic health problems.
Afghanistan’s Opium Ban: Future Implications for Heroin Supply
Nearly all heroin consumed in Europe is derived from opium produced in Afghanistan. However, Afghanistan’s opium production has seen a dramatic decline following the Taliban’s 2022 ban on poppy cultivation, which led to a 95% reduction in production by 2023. While the immediate impact on heroin availability in Europe has been minimal, the report warns that a sustained ban could lead to future heroin shortages. Such shortages could open the door for synthetic opioids to dominate the market.
The decline in Afghan opium cultivation from 233,000 hectares in 2022 to just 10,800 hectares in 2023 has raised concerns about the future of heroin availability in Europe. Should the Taliban continue to enforce the ban, experts believe the resulting heroin scarcity could increase the use of more potent and dangerous synthetic opioids, exacerbating the public health crisis.
The Rise of Synthetic Opioids: Fentanyl and its Analogues
Synthetic opioids, such as fentanyl, are becoming more prevalent in the European drug market. These substances are far more potent than heroin, and even small doses can lead to fatal overdoses. The 2024 report highlights how these synthetic opioids are contributing to a growing number of overdose deaths and hospital emergencies across Europe. In countries such as Estonia and Sweden, fentanyl is responsible for a significant proportion of drug-related deaths.
Fentanyl analogs are particularly concerning because they can be mixed with other drugs like heroin or cocaine, often without the user’s knowledge. The increasing presence of these synthetic opioids is a major public health concern, as traditional harm reduction measures, such as naloxone distribution and needle exchange programs, are less effective against these more potent substances.
Changing Trafficking Routes and Criminal Networks
Traffickers are increasingly adapting their methods in response to heightened enforcement measures and geopolitical developments. The traditional Balkan route, which brings heroin through Turkey and Bulgaria into Europe, has seen increased enforcement and stricter border controls, prompting traffickers to shift towards alternative routes.
The Southern route is becoming more prominent, with significant heroin shipments passing through Iran and Pakistan before reaching Europe via major seaports. The United Arab Emirates (UAE) has emerged as a key transshipment hub for heroin, providing both logistical support and avenues for money laundering. Meanwhile, the ongoing Russia-Ukraine war has prompted criminal networks to modify their trafficking routes, further complicating law enforcement efforts.
Public Health and Harm Reduction Efforts
Harm reduction strategies have had some success in mitigating the impact of opioid use in Europe. Programs such as opioid substitution therapy (OST) and needle exchange have helped reduce the number of new users injecting heroin, thereby lowering the risks of HIV and hepatitis C transmission. However, the growing prevalence of synthetic opioids poses new challenges. These potent drugs often require stronger overdose prevention measures, such as fentanyl test strips and more widespread access to naloxone, an opioid antagonist used to reverse overdoses.
Additionally, the report notes the importance of expanding data collection and improving early warning systems to monitor emerging trends in opioid use and trafficking. These systems allow public health authorities and law enforcement to respond more quickly to new synthetic opioids entering the market.
Challenges in Treating Opioid Addiction
Treatment for opioid addiction, particularly heroin, is evolving. Europe’s aging population of opioid users presents new challenges, as older users are more likely to have complex medical conditions. Many long-term users require not just drug treatment but also social support and healthcare for chronic conditions related to long-term substance use. Furthermore, gender-specific issues are emerging, as women who use opioids face more barriers to accessing treatment and are more likely to present with co-occurring psychological or social issues.
Conclusion
The opioid crisis in Europe is evolving, with heroin still posing a significant threat to public health, while synthetic opioids like fentanyl are emerging as an even more dangerous force. The reduction in Afghan opium production and the shifting trafficking routes complicate the landscape further. To tackle this complex issue, Europe must continue to invest in harm reduction, international cooperation, and early warning systems to prevent more overdose deaths and manage the changing face of the opioid market. Without a coordinated response, Europe risks facing an even more devastating public health crisis in the coming years.
Related
The fact that some people are eating dogs and cats is a highly sensitive topic that crosses cultural, social, and ethical boundaries. In many regions, these animals are consumed due to cultural traditions and necessity, while in other cases, drug-induced behavior may lead individuals to engage in extreme or unusual dietary practices. This article aims to explore the distinction between cultural norms and the desperate, erratic behaviors driven by substance abuse, focusing on the need for cultural sensitivity while addressing harmful behavior.
When Culture Meets Addiction: Who Is Eating Dogs and Cats?
Cultural Practices and the Consumption of Non-Traditional Animals
In some parts of Asia and Africa, the phenomena of eating dogs and cats has historical roots that are tied to both cultural traditions and the availability of resources. In these regions, the eating of non-traditional animals is a normalized practice and is not connected to drug-fueled behavior.
- Cultural Normalcy: In regions such as South Korea, China, and Vietnam, dogs have historically been consumed as part of traditional cuisines. This practice is not driven by addiction or desperation but by cultural norms that view these animals as a food source rather than pets.
- Food Scarcity: In some communities, especially in impoverished or rural areas, consuming non-traditional animals like dogs or cats is a practical response to food scarcity. The decision to eat these animals is based on survival rather than personal preference or altered judgment.
Drug-Induced Dietary Choices: When Addiction Leads to Extreme Behaviors
In contrast to cultural practices, there are cases where individuals under the influence of drugs engage in extreme or bizarre behaviors, such as eating dogs and cats… This behavior is driven by impaired judgment, psychosis, or desperation caused by addiction, and often occurs in isolated or marginalized communities.
- Methamphetamine and Erratic Behavior: Meth users are known to exhibit extreme and irrational behaviors, including eating animals they wouldn’t normally consider food. Meth-induced psychosis can blur the lines between reality and hallucination, leading to bizarre dietary choices such as consuming pets or strays.
- Desperation from Heroin Addiction: Heroin addicts, especially those living in extreme poverty, may consume non-traditional animals out of necessity. Chronic malnutrition and impaired judgment, combined with isolation from society, can drive addicts to make choices they wouldn’t otherwise consider.
Understanding the Cultural vs. Drug-Fueled Divide
It’s crucial to differentiate between cultural practices and behaviors driven by addiction when discussing the consumption of non-traditional animals. Respecting cultural practices while addressing the harmful impacts of substance abuse requires a nuanced understanding of these different contexts.
- Cultural Sensitivity: When discussing the consumption of non-traditional animals, especially in regions where this practice is accepted, it is important to approach the subject with cultural sensitivity. Condemning these practices without understanding their historical and social context can perpetuate stereotypes and breed intolerance.
- Addressing Addiction-Related Behaviors: Conversely, when the consumption of animals like dogs and cats is tied to addiction, the focus should be on treating the root causes of drug abuse rather than criminalizing individuals. Rehabilitation, mental health support, and access to food resources are critical in preventing desperate behaviors.
Ethical Considerations and Animal Welfare
Regardless of whether the consumption of non-traditional animals is driven by culture or desperation, the ethical treatment of animals is a key concern. The dog and cat meat industries have come under scrutiny for their inhumane treatment of animals, and organizations worldwide are working to promote animal welfare and ethical eating practices.
- Animal Rights in Cultural Contexts: While respecting cultural traditions, animal rights organizations are increasingly advocating for more humane practices within these industries. Campaigns to ban or reduce the consumption of dog and cat meat have gained traction, with a focus on reducing cruelty and promoting alternative food sources.
- Animal Cruelty and Drug Addiction: In cases of drug-induced behaviors, the animals involved often suffer from neglect or harm. Providing support for addicts and ensuring animals are removed from harmful environments can help mitigate this issue.
How to Approach the Issue Globally
Addressing the issue of non-traditional animal consumption, whether cultural or drug-fueled, requires a global approach that balances respect for cultural practices with the promotion of humane treatment for animals. Public health initiatives and cultural sensitivity training can help bridge the gap between different viewpoints while ensuring that animals and people alike are treated with dignity.
- Promoting Cultural Understanding: Efforts to educate the public on the cultural contexts of eating non-traditional animals can help reduce prejudice and promote more respectful global dialogues. Cultural exchange programs and educational campaigns can provide a more nuanced view of these practices.
- Addressing Substance Abuse: On the other hand, combatting the desperation and irrational behavior caused by addiction requires investments in mental health, addiction treatment, and public welfare systems. Providing addicts with support, housing, and access to food can reduce the likelihood of harmful or extreme behaviors.
Conclusion
While the consumption of non-traditional animals like dogs and cats may be culturally accepted in some regions, drug-induced behaviors that lead to similar actions must be understood in a different light. It’s important to address addiction-related behavior with compassion, focusing on rehabilitation and support rather than punishment. At the same time, promoting animal welfare and humane practices in regions where these animals are consumed can create a more ethical global community. By approaching these issues with respect for cultural diversity and a commitment to reducing harm, both animals and humans can benefit.
Related
Autoimmune Conditions Are Rising Fast in American Medicine, Can Cannabis Help?
Hemp and the New Senate Farm Bill
The Red Wall Blocking Marijuana Legalization in America, Real or Imagined?
Minnesota Office of Cannabis Management Issues Rejections to Majority of Social Equity Applicants
Find LivWell in Colorado
Find Verilife in Massachusetts
Find Verilife in Illinois
Find Verilife in New York
Ohio Non-Medical Cannabis is available at Verilife
Where quality meets savings: Independently owned Giving Tree offers fantastic deals
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing11 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse